The process of public policy formulation: The case of thimerosal in vaccines

Pediatrics

Volumn 109, Issue 6, 2002, Pages 1153-1159

  Freed, Gary L ^a,b   Andreae, Margie C ^a   Cowan, Anne E ^a   Katz, Samuel L ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THIOMERSAL; VACCINE;

ARTICLE; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; INTERVIEW; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES; VACCINE PRODUCTION;

HEALTH POLICY; HUMANS; THIMEROSAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VACCINES;

EID: 0036267156     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.109.6.1153     Document Type: Article

References (25)

1. Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service
2. An assessment of thimerosal use in childhood vaccines
3. Notice: Mercury compounds in drugs and foods; request for data and information
4. Action level for mercury in fish, shellfish, crustaceans, and other aquatic animals
5. Preventing harm from thimerosal in vaccines
6. Preventing harm from thimerosal in vaccines
7. Universal hepatitis B immunization of infants: Reactions of pediatricians and family physicians over time
8. Pediatrician and family physician agreement with and adoption of universal hepatitis B immunization
9. Hospitals' responses to universal infant hepatitis B vaccination recommendations
10. Hepatitis B maternal screening, infant vaccination, and infant prophylaxis practices in North Carolina
11. Regional differences in infant immunization against hepatitis B: Did intervention work?
12. Impact of the 1999 AAP/US PHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices
13. Impact of the joint statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices
14. Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine
15. Hepatitis B vaccination practices in hospital newborn nurseries before and after changes in vaccine recommendations
16. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:20:1:3 vaccine series
17. Safety of vaccinations. Miss America, the media, and public health